Skip to main content
Fig. 3 | BMC Pharmacology and Toxicology

Fig. 3

From: The efficacy and safety of high-dose nonsedating antihistamines in chronic spontaneous urticaria: a systematic review and meta-analysis of randomized clinical trials

Fig. 3

A-1 Forest plot of response rate comparing high-dose with standard-dose sgAHs.(subgroup by dose). A-2 Forest plot of response rate comparing high-dose with standard-dose sgAHs.(subgroup by drug). B-1 Forest plot of adverse events comparing high-dose with standard-dose sgAHs.(subgroup by dose). B-2 Forest plot of adverse events comparing high-dose with standard-dose sgAHs.(subgroup by drug). C-1 Forest plot of somnolence comparing high-dose with standard-dose sgAHs.(subgroup by dose). C-2 Forest plot of somnolence comparing high-dose with standard-dose sgAHs.(subgroup by drug). D-1 Forest plot of comparing withdrawal of patients due to adverse events between high-dose and standard-dose sgAHs treatment.(subgroup by dose). D-2 Forest plot of comparing withdrawal of patients due to adverse events between high-dose and standard-dose sgAHs treatment.(subgroup by drug)

Back to article page